Beta-blocker effects on heart rate and exercise capacity in atrial fibrillation
Part of Heart & circulation clinical trials.
This study looks at how taking a beta-blocker affects your resting heart rate during activity and how fit your heart and lungs are during an exercise test. It may help clarify whether the way the medication controls heart rate is linked to better exercise tolerance in people with persistent atrial fibrillation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re over 20 years old.
- You have persistent atrial fibrillation and take a beta-blocker specifically to control your heart rate.
- Your beta-blocker dose has not changed for at least 3 months.
- Your resting heart rate is under 80 beats per minute.
- Your heart’s pumping strength (left ventricular ejection fraction) is above 50%.
- You can safely complete a cardiopulmonary (exercise) test and give informed consent.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if a specific exercise program can reduce how often atrial fibrillation (a type of irregular heartbeat) happens. If you have non-permanent atrial fibrillation and are willing to follow an exercise plan, this trial might help you manage your condition.
This trial studies how an exercise training program affects people with persistent or permanent atrial fibrillation (an irregular heart rhythm). It may help improve how you feel and how well your heart and body handle activity.
This trial tests whether exercise can help people with atrial fibrillation (an irregular heart rhythm that can come and go or last for a while). You might benefit if you have this condition, are between 18 and 80, and have not been very active.
This study tests whether using a Fitbit activity tracker and a supportive exercise program helps people with AFib become more active. It may help you feel better and manage your heart rhythm.
This study follows people with atrial fibrillation to see how well blood-thinning medications work and what outcomes they experience over time. It aims to improve treatment guidance for patients with this common heart rhythm condition.
This study looks at early changes in the heart related to atrial fibrillation (AF) using health data and biomarkers. It aims to find better ways to predict or understand AF, especially around procedures like ablation or cardioversion.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.